Cocrystal Pharma Inc. said its shares were approved for listing on the Nasdaq Capital Market.
The company's common stock commenced trading on the market March 12 under the symbol COCP.
Tucker, Ga.-based Cocrystal is a clinical stage biotechnology company developing treatments for hepatitis, influenza and noroviruses.
Nasdaq Capital Markets are focused on helping companies raise capital.
